Muramidase: Clinical Trials

5 trials of Muramidase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting. 2 Not applicable, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Recruiting 1
Phase 32Completed 1, Recruiting 1
Phase 41Completed 1

Follow Muramidase: new trials by email Literature Review of Muramidase trials Research Report on Muramidase

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients
Oral7® mouth spray contains Natural Enzymes (Lactoperoxidase, Glucose Oxidase, Lactoferrin, Lysozyme), Calcium, Xylitol, Aloe Vera, Natural peppermint. - Xerostomia, Geriatric
Not applicableRecruitingZAINAB MAT YUDIN1002025-09-182026-05-22
Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae
Lactoferrin, Lysozyme, Lactoferrin + Lysozyme - Diarrhea, Wasting
Phase 3RecruitingUniversity of Washington6002023-03-102025-09-11
Comparison of Gum® HydralTM Moisturizing Gel and Biotene® Oral Gel in Dry Mouth Sensation Reduction
Betaine taurine PVP gel, Xylitol, Lactoperoxidase, Lysozyme, Lactoferrin - Xerostomia
Phase 3CompletedAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia402017-09-222022-04-22
Lactoferrin and Lysozyme Supplementation for Environmental Enteric Dysfunction
Lactoferrin, Lysozyme, Placebo - Environmental Enteric Dysfunction
Not applicableCompletedWashington University School of Medicine2352016-10-012018-05-02
Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom
lysozyme 90 mg, Placebo - Chronic Obstructive Pulmonary Disease, Asthma
Phase 4CompletedEisai Co., Ltd.482012-10-012014-07-18

Conditions studied

Xerostomia (2)  ·  Asthma (1)  ·  Cachexia (1)  ·  Child Nutrition Disorders (1)  ·  Diarrhea (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1)  ·  Eisai Co., Ltd. (1)  ·  University of Washington (1)  ·  Washington University School of Medicine (1)  ·  ZAINAB MAT YUDIN (1)

Countries

Italy (1)  ·  Japan (1)  ·  Kenya (1)  ·  Malawi (1)  ·  Malaysia (1)

Top investigators

Chrissie Thakwalakwa, PhD (1)  ·  Domenico Dalessandri, Prof. (1)  ·  Indi Trehan, MD MPH DTM&H (1)  ·  Kai Shibata (1)  ·  Mark J Manary, MD (1)  ·  Patricia B Pavlinac (1)

Results publications

PMID 29110675, PMID 39122384

NIH funding

R01HD103642 (1)